Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer

NCT07271823 is registered in ClinicalTrials.gov with Zhejiang Cancer Hospital as lead sponsor.

NCT NCT07271823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07271823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
Lead sponsor
Zhejiang Cancer Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
September 1, 2024
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer non-resectable